No Data
No Data
Gansu Yatai Industrial Development (000691.SZ): Signed a Comprehensive Strategic Cooperation Agreement with Pingshan Biomedical Research Institute of South China University of Technology.
On October 14, Gansu Yatai Industrial Development (000691.SZ) announced that, based on the principle of complementary advantages and mutual benefit, the company has formed a strategic partnership with the Pingshan Biomedical Research Institute of Southern University of Science and Technology in the commercialization of the pharmaceutical green catalysis technology platform. A cooperation agreement has been reached on the key intermediate projects, and on October 14, 2024, in Shenzhen, the "Comprehensive Strategic Cooperation Agreement" was signed, with a term of 3 years. The cooperation includes the construction of active pharmaceutical ingredient intermediate production base; the design of production lines for key chiral intermediates such as ibuprofen and tegrelor; targeting the top 200 species of active pharmaceutical ingredients globally.
Gansu Yatai Industrial Developent Co.,Ltd.'s (SZSE:000691) 26% Share Price Surge Not Quite Adding Up
Asia Pacific Industries: Semi-Annual Report 2024
Asia Pacific Industries: 2024 Semi-Annual Report Summary
Gansu Yatai Industrial Development (000691.SZ) released its performance for the first half of the year, with a net loss of 14.1936 million yuan.
Gansu Yatai Industrial Development (000691.SZ) released the 2024 interim report. During the reporting period, the company achieved revenue...
Gansu Yatai Industrial Development (000691.SZ): net loss of 14.1936 million yuan in the first half of the year, an expanded loss compared to the same period last year.
Gansu Yatai Industrial Development (000691.SZ) announced its semi-annual report for 2024, with a total operating income of 0.244 billion yuan, a year-on-year increase of 15.54%; net income attributable to shareholders of listed companies was -14.1936 million yuan, with an expanded year-on-year loss; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was -14.6179 million yuan, with an expanded year-on-year loss; basic earnings per share was -0.0439 yuan.
No Data
No Data